Savencia is a transformer of milk centered on cheese, dairy specialties, and on dairy ingredients. Co.'s operations are divided into two segments: the Cheese Products segment and the Other Dairy Products segment. In the Cheese Products segment, Co. manufactures and distributes cheeses and cheese specialties. In the Other Dairy Products segment, Co. manufactures and distributes modern butters and long-life creams both for final consumers and professional users, manufactures technical butters and specialized dairy proteins for industrial markets, and manufactures aseptically packaged products.
  • TickerSAVE
  • ISINFR0000120107
  • ExchangeEuronext Paris
  • SectorFood Producers
  • CountryFrance

Analysts

Fatma Agnès Hamdani

Savencia SA : A solid quarter. Relatively cautious on the rest of the year. We are still at Buy

>Solid organic growth in Q3 underpinned by price effects - Organic sales growth in Q3 of 5.2% reflects growth of 4.3% for cheese products and +8.2% for other dairy products. The volume mix for cheese products remains solid at +2.7%, despite a warm summer in Europe and a higher price effect of +1.6% than in H1 (+0.4%). This reflects the price increases introduced in some eastern European countries and in Russia which did not see any impact on volumes. In France, ...

Fatma Agnès Hamdani

Savencia SA : Un trimestre solide. Relative prudence sur le reste de l’année. Achat réitéré

>Une croissance organique solide au T3 soutenue par les effets prix - La croissance organique du CA T3 de 5.2% reflète une croissance de 4.3% pour les Produits fromagers et +8.2% pour les Autres produits laitiers. Le mix volume pour les Produits fromagers reste solide à +2.7%, en dépit d’un été chaud en Europe et d’un effet de prix de +1.6% plus élevé qu’au S1 (+0.4%). Ceci reflète les hausses de prix passées dans certains pays d’Europe de l’Est ou encore en Rus...

Alexandre Iatrides ...
  • Aurelien Sivignon
  • Baptiste Lebacq
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Emmanuel Matot
  • Fatma Agnès Hamdani
  • Hela Zarrouk
  • Jean-François Granjon
  • Jeremy Garnier
  • Jerôme Bodin
  • Rémi Adam

ODDO BHF Small & MIDCAP MORNING NEWS - 10/25/2019

...

Fatma Agnès Hamdani

Savencia SA : Q3/9M sales in line with our expectations with solid organic growth of 5.2% in Q3. Caution maintained on the rest of the year

>Organic growth of +5.2% in Q3, slightly higher than our estimate of 4.8% - Yesterday evening Savencia reported Q3/9-month sales in line with our estimates. Nine-month sales were up 3.4% to € 3,648m (vs Oddo BHF estimate: € 3,646.7m). The -1.7% forex effect was in line and the +0.5% impact from changes to the consolidation scope stemmed notably from the consolidation of cheesemaker Rogue in the US. Organic growth of 4.8% was close to our estimate of +4.7%. Organic gro...

Alexandre Iatrides ...
  • Aurelien Sivignon
  • Baptiste Lebacq
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Emmanuel Matot
  • Fatma Agnès Hamdani
  • Hela Zarrouk
  • Jean-François Granjon
  • Jeremy Garnier
  • Jerôme Bodin
  • Rémi Adam

ODDO BHF Small & MIDCAP MORNING NEWS - 25/10/2019

...

Fatma Agnès Hamdani

Savencia SA : A solid quarter. Relatively cautious on the rest of the year. We are still at Buy

>Solid organic growth in Q3 underpinned by price effects - Organic sales growth in Q3 of 5.2% reflects growth of 4.3% for cheese products and +8.2% for other dairy products. The volume mix for cheese products remains solid at +2.7%, despite a warm summer in Europe and a higher price effect of +1.6% than in H1 (+0.4%). This reflects the price increases introduced in some eastern European countries and in Russia which did not see any impact on volumes. In France, ...

Fatma Agnès Hamdani

Savencia SA : Un trimestre solide. Relative prudence sur le reste de l’année. Achat réitéré

>Une croissance organique solide au T3 soutenue par les effets prix - La croissance organique du CA T3 de 5.2% reflète une croissance de 4.3% pour les Produits fromagers et +8.2% pour les Autres produits laitiers. Le mix volume pour les Produits fromagers reste solide à +2.7%, en dépit d’un été chaud en Europe et d’un effet de prix de +1.6% plus élevé qu’au S1 (+0.4%). Ceci reflète les hausses de prix passées dans certains pays d’Europe de l’Est ou encore en Rus...

Fatma Agnès Hamdani

Savencia SA : Q3/9M sales in line with our expectations with solid organic growth of 5.2% in Q3. Caution maintained on the rest of the year

>Organic growth of +5.2% in Q3, slightly higher than our estimate of 4.8% - Yesterday evening Savencia reported Q3/9-month sales in line with our estimates. Nine-month sales were up 3.4% to € 3,648m (vs Oddo BHF estimate: € 3,646.7m). The -1.7% forex effect was in line and the +0.5% impact from changes to the consolidation scope stemmed notably from the consolidation of cheesemaker Rogue in the US. Organic growth of 4.8% was close to our estimate of +4.7%. Organic gro...

Fatma Agnès Hamdani

Savencia SA : CA T3/9M en ligne avec nos attentes avec une croissance organique solide de 5.2% au T3. Prudence maintenue sur le reste de l'année

>Une croissance organique de +5.2% au T3, légèrement au-dessus de notre estimation de 4.8% - Savencia a publié hier soir sur CA T3/9 mois en ligne avec nos attentes. Les ventes 9M ressortent en hausse de 3.4% à 3 648 M€ (vs 3 646.7 M€e). L’effet de change de -1.7% est en ligne et l’effet périmètre de +0.5% tient compte notamment de la consolidation de la fromagerie Rogue aux US. La croissance organique de 4.8% est proche à nos anticipations (+4.7%e). Cette croissance ...

Fatma Agnès Hamdani

Savencia SA : Continuing improvement in profitability

>Very dynamic Q2 for cheese products - Organic growth came to 4.7% in H1, reflecting strong momentum in the two businesses in Q2, with  increases in sales of 5.4% for cheese products and +8.9% for other dairy products. Momentum was driven by a price effect of 3.2% in H1 with +3.8% in Q2 by our calculations. The estimated volume mix of 1.5% improved sharply in Q2 thanks to cheese products (+2.5% in H1 vs 0.3% in Q1). It increased in certain European countries incl...

A director bought 1,300 shares at 80.500EUR and

A director at Savencia S.A. bought 1,300 shares at 80.500EUR and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of...

Alexandre Iatrides ...
  • Aurelien Sivignon
  • Baptiste Lebacq
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Emmanuel Matot
  • Fatma Agnès Hamdani
  • Hela Zarrouk
  • Jean-François Granjon
  • Jeremy Garnier
  • Jerôme Bodin
  • Rémi Adam

ODDO BHF Small & MIDCAP MORNING NEWS - 10/25/2019

...

Alexandre Iatrides ...
  • Aurelien Sivignon
  • Baptiste Lebacq
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Emmanuel Matot
  • Fatma Agnès Hamdani
  • Hela Zarrouk
  • Jean-François Granjon
  • Jeremy Garnier
  • Jerôme Bodin
  • Rémi Adam

ODDO BHF Small & MIDCAP MORNING NEWS - 25/10/2019

...

Benoit Valleaux ...
  • Charles Lepetitpas
  • Fatma Agnès Hamdani
  • Jean-François Granjon
  • Nicolas David
  • Roland Pfaender,MBA,CFA,CCRA

ODDO BHF Small & MIDCAP MORNING NEWS - 09/09/2019

...

Benoit Valleaux ...
  • Charles Lepetitpas
  • Fatma Agnès Hamdani
  • Jean-François Granjon
  • Nicolas David
  • Roland Pfaender,MBA,CFA,CCRA

ODDO BHF Small & MIDCAP MORNING NEWS - 09/09/2019

...

Alfred Glaser ...
  • Antoine Boivin-Champeaux
  • Bruno Cavalier
  • Charles Lepetitpas
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Delphine Brault
  • Fatma Ayachi
  • Fatma Agnès Hamdani
  • Geoffroy Michalet
  • Hela Zarrouk
  • Jeremy Garnier
  • Nicolas David
  • Stephane Houri
  • Yan Derocles

ODDO BHF Small & MIDCAP MORNING NEWS - 09/06/2019

We estimate the increase in NAV at end-June at 17% (+€ 643m) to € 4.4bn (€ 176 per share). At 4 September, the increase is slightly lower (+15%). The discount has returned to a historically high level (46% at end-June, 49% at present). In the future, the valuation should continue to increase thanks to a twin source of leverage: the continued rise in NAV and the reduction of the discount. We confirm our Buy recommendation and have edged up our target price to € 134 vs € 132. - Cf. com...

SAVENCIA is slightly downgraded to Slightly Positive due to an increasingly adverse environment

The independent financial analyst theScreener just slightly lowered the general evaluation of SAVENCIA (FR), active in the Food Products industry. As regards its fundamental valuation, the title confirms its rating of 2 out of 4 stars while its market behaviour remains unchanged and can be qualified as defensive. However, a marginally less favourable environment forces theScreener to downgrade slightly the title, which now shows an overall rating of Slightly Positive. As of the analysis date September 6, 2019, the closing price was EUR 65.80 and its potential was estimated at EUR 74.01.

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...

MarketLine Department

Emmi AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments

Summary Marketline's Emmi AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Emmi AG since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Key Highlights This re...

Jehanne Leroy

Etude de l'AG du 27/04/2017

Tout d'abord, Proxinvest souhaite attirer l'attention des actionnaires sur la décision du Conseil d'administration, en date du 20 avril 2016, de dissocier les fonctions de Président du Conseil d'administra

Matthieu DRIOL

Analyse court terme - SAVENCIA : La tendance de fond est clairement orientée à la baisse.

La tendance de fond est clairement orientée à la baisse. Les prix baissent à nouveau, mais le mouvement est devenu hésitant. Le prochain support est à 62,55 €. La tendance de fond serait remise en cause en cas de franchissement de 78,00 €.

Matthieu DRIOL

Short term view - SAVENCIA : The background trend is clearly bearish.

The background trend is clearly bearish. Prices are falling again, but the movement has become hesitant. The next support is at €62.55. The background trend would be questioned should prices rise above €78.00.

Matthieu DRIOL

Short term view - SAVENCIA : Falling prices.

The background trend is clearly bearish. Prices are falling again, but the movement has become hesitant. The next support is at €64.81. The background trend would be questioned should prices rise above €78.00.

Matthieu DRIOL

Analyse court terme - SAVENCIA : Les prix baissent.

La tendance de fond est clairement orientée à la baisse. Les prix baissent à nouveau, mais le mouvement est devenu hésitant. Le prochain support est à 64,81 €. La tendance de fond serait remise en cause en cas de franchissement de 78,00 €.

Matthieu DRIOL

Medium term view - SAVENCIA : The trend is bearish.

The trend is bearish. The movement goes on. The next target is at €62.55, then €52.24. Passing €90.80 would question the continuation of the fall.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch